Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...
Weight loss jabs, known as GLP-1 receptor agonists, work by reducing food cravings. In October, the MHRA told health ...
Novo Nordisk announced positive trial results for its next-generation obesity drug, leading to a 7.13% surge in its share ...
There are precedents for a hybrid NHS-private model of healthcare. Ten years ago, a new drug treatment arrived that could ...
Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...
The new treatment targets gut hormone GLP-1 but also mimics amylin, a hormone released by the pancreas that suppresses hunger ...
Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...
As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...
A woman who lost 64 pounds on a compounded form of the weight loss drug semaglutide, marketed as Wegovy and Ozempic, started ...
Recent research reveals that weight-loss injections reduce the risk of 42 health conditions in people with diabetes, ...
A major new study has highlighted significant health risks associated with popular weight loss injections such as Ozempic, ...
Liraglutide, a daily GLP-1 drug, brought weight loss of up to 5.8% after 26 weeks. A pill form of semaglutide brought similar weight loss as injections, according to the analysis. The FDA approved ...